FGFR2 and pancreatic ductal adenocarcinoma: Notably, ATP6V0D1 deletion exerted distinct effects in pancreatic ductal adenocarcinoma (PDAC) models, differentiating FGFR2-dependent (SW1990) from FGFR2-independent (MIAPaCa2) subtypes.